Market Place
Sourcing Support
All News #Library
Biotech
Accord Biopharma`s Hercessi Receives Preferred Status
05 Jan 2026 //
PR NEWSWIRE
Accord Biopharma Adds IMULDOSA To Express Scripts Formularies
01 Dec 2025 //
PR NEWSWIRE
Accord Biopharma Gets FDA Nod For Denosumab Biosimilars Osvyrti
20 Nov 2025 //
PR NEWSWIRE
Bio-Thera Announces Expansion of Partnership with Intas Pharma
09 Oct 2025 //
PR NEWSWIRE
Coherus completes successful divestiture of Udenyca Franchise
14 Apr 2025 //
GLOBENEWSWIRE
Bio-Thera Signs Licensing Deal with Intas Pharma for BAT2506
10 Feb 2025 //
PR NEWSWIRE
Coherus Biosciences Sells Udenyca Franchise to Intas Pharma
04 Dec 2024 //
PRESS RELEASE
Accord Healthcare Receives Positive CHMP Opinion for Imuldosa
19 Oct 2024 //
PR NEWSWIRE
Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY
21 Sep 2024 //
PR NEWSWIRE
Accord BioPharma’s HERCESSI secures FDA approval
30 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
Intas inks agreement for treating autoimmune diseases in 150+ countries
20 Dec 2023 //
BIOSPECTRUM ASIA
Henlius Deepens Collaboration with Intas to bring Serplulimab to Europe & India
27 Oct 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.